TW200612967A - Anti-viral uses of borinic acid complexes - Google Patents

Anti-viral uses of borinic acid complexes

Info

Publication number
TW200612967A
TW200612967A TW094119708A TW94119708A TW200612967A TW 200612967 A TW200612967 A TW 200612967A TW 094119708 A TW094119708 A TW 094119708A TW 94119708 A TW94119708 A TW 94119708A TW 200612967 A TW200612967 A TW 200612967A
Authority
TW
Taiwan
Prior art keywords
acid complexes
borinic acid
viral uses
viral
borinic
Prior art date
Application number
TW094119708A
Other languages
English (en)
Chinese (zh)
Inventor
Jacob J Plattner
Kirk R Maples
Carolyn Bellinger-Kawahara
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of TW200612967A publication Critical patent/TW200612967A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094119708A 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes TW200612967A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14

Publications (1)

Publication Number Publication Date
TW200612967A true TW200612967A (en) 2006-05-01

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094119708A TW200612967A (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Country Status (12)

Country Link
US (1) US7393856B2 (enExample)
EP (1) EP1765360B1 (enExample)
JP (1) JP2008502694A (enExample)
AT (1) ATE447960T1 (enExample)
BR (1) BRPI0512049A (enExample)
CA (1) CA2570577A1 (enExample)
DE (1) DE602005017626D1 (enExample)
ES (1) ES2333244T3 (enExample)
MX (1) MXPA06014417A (enExample)
PT (1) PT1765360E (enExample)
TW (1) TW200612967A (enExample)
WO (1) WO2006085932A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006332797A1 (en) * 2005-12-28 2007-07-12 Anacor Pharmaceuticals, Inc. Process for manufacturing picolinate borinic esters
BRPI0708051A2 (pt) 2006-02-16 2011-05-17 Anacor Pharmaceuticals Inc moléculas pequenas contendo boro como agentes antiflamatórios
JP5606913B2 (ja) * 2008-08-11 2014-10-15 独立行政法人科学技術振興機構 蛋白質架橋阻害剤
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
UY35287A (es) 2013-01-30 2014-08-29 Dow Agrosciences Llc Uso de benzoxaborolas como agentes antimicrobianos volátiles en carnes, plantas o partes de plantas.
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR101756785B1 (ko) 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
TWI883391B (zh) * 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788800A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
EP1581500A4 (en) 2002-12-18 2008-03-05 Anacor Pharmaceuticals Inc ANTIBIOTICS CONTAINING BORINIC ACID COMPLEXES AND METHODS OF USE

Also Published As

Publication number Publication date
EP1765360A2 (en) 2007-03-28
DE602005017626D1 (de) 2009-12-24
CA2570577A1 (en) 2006-08-17
EP1765360B1 (en) 2009-11-11
JP2008502694A (ja) 2008-01-31
BRPI0512049A (pt) 2008-02-06
WO2006085932A2 (en) 2006-08-17
US7393856B2 (en) 2008-07-01
WO2006085932A3 (en) 2006-10-05
ATE447960T1 (de) 2009-11-15
PT1765360E (pt) 2009-12-24
ES2333244T3 (es) 2010-02-18
HK1102702A1 (en) 2007-11-30
MXPA06014417A (es) 2007-03-08
US20060019927A1 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
WO2007131072A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
WO2008054454A3 (en) Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200606162A (en) Pyrazolopyridine derivatives
TW200612967A (en) Anti-viral uses of borinic acid complexes
TW200510343A (en) Substituted dihydroquinazolines
UA95105C2 (ru) Применение производного лактамида для снижения токсичности в препарате, который может соприкасаться с кожей или глазами человека или животного, производные лактамида и способы их получения
MX272108B (es) Heterociclos sustituidos.
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
TW200612966A (en) Boron-containing compounds and methods of use
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
GB2442915B (en) Perylenequinone derivatives and uses thereof
TW200724537A (en) Pyrimidine derivatives for treatment of hyperproliferative disorders
DE502005002176D1 (de) Substituierte chinolone
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
WO2006088903A3 (en) Pyrazole compounds
TW200726763A (en) Novel compound
TW200610530A (en) Anti-parasitic uses of borinic acid complexes
TW200700411A (en) Heterocyclylamide-substituted imidazoles
TW200609222A (en) Diazole derivatives
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
WO2007081540A3 (en) Tylophorine analogs as antitumor agents